Anti-alzheimer and antioxidant activity of celastrus paniculatus seed

Iranian Journal of Pharmaceutical Sciences

Volumn 7, Issue 1, 2011, Pages 49-56

  Alama, Badrul ^b   Haque, Ekramul ^a  

^a BRAC UNIVERSITY   (Bangladesh)

^b NONE

Author keywords

Anti alzheimer; Antioxidant; Celastrus paniculatus; Cholinesterase; ROS

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; CELASTRUS PANICULATUS EXTRACT; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; TROLOX C;

ANTIALZHEIMER ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLINESTERASE INHIBITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; IC 50; PLANT SEED;

EID: 84857537896     PISSN: 17352444     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jann MW. Preclinical pharmacology of metriphonate. Pharmacotherapy 1998; 18: 215-25.
2. Adams RL, Crai PL, Parsons OA. Neuropsychology of dementia. Neurolog Clin 1984; 4: 387-405.
3. Aisen PS, Davis KL. The search for diseasemodifying treatment for Alzheimer's Disease. Neurology 1997; 48: 35-41.
4. Johnson N, Davis T, Bosanquet N. The epidemic of Alzheimer's disease; how can we manage the costs? Pharmacogenomics 2000; 18: 215-23.
5. Camps P, El-Achab R, Morral J, Torrero DM, Badia A, Banos JE, Vivas NM, Barril X, Orozco M, Luque FJ. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease. J Med Chem 2000; 43: 4657-66.
6. Parihar MS, Hemnani T. Alzheimer's disease pathogenesis and therapeutic interventions. J Clin Neurosci 2004; 11: 456-67.
7. Enz A, Amstutz R, Boddeke H, Gmelin G, Malonowski J. Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease. Prog Brain Res 1993; 98: 431-45.
8. Torreilles F, Salman-Tabcheh S, Guerin M, Torreilles J. Neurodegenerative disorders: the role of peroxynitrite. Brain Res Rev 1999; 30: 153-63.
9. Butterfield DA, Reed T, Newman SF, Sultana R. Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Rad Bio Med 2007; 43: 658-77.
10. Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Rad Bio Med 1997; 23: 134-47.
11. Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide. Trends Mol Med 2001; 7: 548-54.
12. Tran MH, Yamada K, Nakajima A, Mizuno M, He J, Kamei H, Nabeshima T. Tyrosine nitration of a synaptic protein synaptophysin contributes to amyloid β-peptide-induced cholinergic dysfunction. Mol Psyc 2003; 8: 407-12.
13. Gaitonde BB, Raiker KP, Shroff FN, Patel JR. Pharmacological studies with Malkangunin indigenous tranquilizing drug. Curr Med Prac 1957; 1: 619-21.
14. Ahmad R, Khan RA, Rasheed S. Preliminary screening of methanolic extract of Celastrus paniculatus and Tecomella undulate for analgesic and anti-inflammatory activities. J Ethnopharm 1994; 42: 193-8.
15. Karanth KS, Padma TK, Gunasundari MN. Influence of Celastrus oil on learning and memory. Arogya 1981; 7: 83-6.
16. Hakim RA. A trial report on Malkanguni oil with other indigenous drugs in the treatment of psychiatric cases. Gujarat State Branch of Med Bul 1964; 77-8.
17. Nalini K, Aroor AR, Kumar RA. Studies on biogenic amines and their metabolites in mentally retarded children on Celastrus oil therapy. Alter Med 1986; 1: 355-60.
18. Nalini K, Karanth KS, Rao A, Aroor AR. Effects of Celastrus paniculatus on passive avoidance performance and biogenic amine turnover in albino rats. J Ethnopharm 1995; 17: 101-8.
19. Gattu M, Boss KL, Alvin V, Terry JR, Buccafusco J. Reversal of scopolamine induced deficits in navigational memory performance by the seed oil of Celastrus paniculatus. Pharm Biochem Behavior 1997; 57: 793-9.
20. Russo A, Izzo A, Cardile V, Borelli F, Vanella A. Indian medicinal plants as antiradicals and DNA cleavage protectors. Phytomedicine 2001; 8: 125-32.
21. Braca A, Tommasi ND, Bari LD, Pizza C, Politi M, Morelli I. Antioxidant principles from Bauhinia terapotensis. J Nat Prod 2001; 64: 892-5.
22. Kooy NW, Royall JA, Ischiropoulos H, Beckman JS. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Rad Bio Med 1994; 16: 149-56.
23. Label CP, Bondy SC. Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes. Neurochem Inter 1990; 17: 435-41.
24. Ellman GL, Courtney D, Andress V and Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95.
25. Hebert LE, Scherr PA, Beckeff LA. Age-specific incidence of Alzheimer's disease in a community population. J Am Med Assoc 1995; 273: 1354-9.
26. Beard CM, Kokmen E, Kurland LT. Prevalence of dementia is changing over time in Rochester, Minnesota. Neurology 1995; 45: 75-9.
27. Arnold SE, Kumar A. Reversible dementias. Med Clin North America 1993; 77: 215-25.